Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - Amendment

22nd Nov 2018 14:04

FORM 8.3 - Amendment to Purchases

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 20 November 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,089,637 1.40% 12,358,178 1.56%
(2) Cash-settled derivatives:
11,758,486 1.48% 10,145,716 1.28%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,521,600 1.32% 10,941,600 1.38%
TOTAL: 33,369,723 4.20% 33,445,494 4.21%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 12,000 19.6103 USD
ADR Sale 12,000 19.6103 USD
Ordinary NPV Purchase 35 4,419.4285 JPY
Ordinary NPV Purchase 300 4,370.0000 JPY
Ordinary NPV Purchase 600 4,422.3333 JPY
Ordinary NPV Purchase 700 4,421.7142 JPY
Ordinary NPV Purchase 700 4,420.8571 JPY
Ordinary NPV Purchase 800 4,416.9000 JPY
Ordinary NPV Purchase 927 4,412.9406 JPY
Ordinary NPV Purchase 1,000 4,417.4000 JPY
Ordinary NPV Purchase 1,054 4,438.4431 JPY
Ordinary NPV Purchase 1,172 4,421.0878 JPY
Ordinary NPV Purchase 1,200 4,445.2500 JPY
Ordinary NPV Purchase 1,227 4,423.7563 JPY
Ordinary NPV Purchase 1,248 4,416.4551 JPY
Ordinary NPV Purchase 1,300 4,451.3076 JPY
Ordinary NPV Purchase 1,859 4,439.0091 JPY
Ordinary NPV Purchase 2,084 4,440.0695 JPY
Ordinary NPV Purchase 2,200 4,406.5000 JPY
Ordinary NPV Purchase 2,500 4,412.9000 JPY
Ordinary NPV Purchase 2,600 4,438.7153 JPY
Ordinary NPV Purchase 3,133 4,429.4711 JPY
Ordinary NPV Purchase 3,600 4,441.1027 JPY
Ordinary NPV Purchase 5,400 4,429.4166 JPY
Ordinary NPV Purchase 6,961 4,452.5151 JPY
Ordinary NPV Purchase 11,000 4,424.7454 JPY
Ordinary NPV Purchase 13,500 4,421.5037 JPY
Ordinary NPV Purchase 15,100 4,433.5496 JPY
Ordinary NPV Purchase 16,800 4,446.1190 JPY
Ordinary NPV Purchase 43,800 4,418.1849 JPY
Ordinary NPV Purchase 58,300 4,418.1029 JPY
Ordinary NPV Purchase 64,300 4,415.0558 JPY
Ordinary NPV Purchase 89,800 4,426.6865 JPY
Ordinary NPV Purchase 98,500 4,476.0000 JPY
Ordinary NPV Purchase 132,700 4,439.1137 JPY
Ordinary NPV Purchase 180,200 4,417.8263 JPY
Ordinary NPV Purchase 437,900 4,425.2301 JPY
Ordinary NPV Purchase 575,400 4,423.2911 JPY
Ordinary NPV Sale 200 4,461.0000 JPY
Ordinary NPV Sale 300 4,429.6666 JPY
Ordinary NPV Sale 600 4,422.3333 JPY
Ordinary NPV Sale 700 4,420.8571 JPY
Ordinary NPV Sale 700 4,412.1428 JPY
Ordinary NPV Sale 1,200 4,370.6666 JPY
Ordinary NPV Sale 2,200 4,392.4090 JPY
Ordinary NPV Sale 2,400 4,385.1250 JPY
Ordinary NPV Sale 2,500 4,412.9000 JPY
Ordinary NPV Sale 2,500 4,448.4000 JPY
Ordinary NPV Sale 2,600 4,438.7153 JPY
Ordinary NPV Sale 3,600 4,441.1027 JPY
Ordinary NPV Sale 6,200 4,427.8016 JPY
Ordinary NPV Sale 8,300 4,370.0000 JPY
Ordinary NPV Sale 15,100 4,433.5496 JPY
Ordinary NPV Sale 26,100 4,461.8927 JPY
Ordinary NPV Sale 44,500 4,418.2404 JPY
Ordinary NPV Sale 55,300 4,407.9367 JPY
Ordinary NPV Sale 58,300 4,417.4837 JPY
Ordinary NPV Sale 64,300 4,415.0558 JPY
Ordinary NPV Sale 89,800 4,426.6865 JPY
Ordinary NPV Sale 436,800 4,432.3608 JPY
Ordinary NPV Sale 437,900 4,425.2301 JPY
Ordinary NPV Sale 575,400 4,423.2911 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV CFD Long 24,000 4,369.5630 JPY
Ordinary NPV SWAP Short 35 4,419.4419 JPY
Ordinary NPV SWAP Short 600 4,436.8333 JPY
Ordinary NPV SWAP Short 927 4,412.9403 JPY
Ordinary NPV SWAP Short 1,054 4,438.4438 JPY
Ordinary NPV SWAP Short 1,172 4,421.0882 JPY
Ordinary NPV SWAP Short 1,227 4,423.7559 JPY
Ordinary NPV SWAP Short 1,248 4,416.4553 JPY
Ordinary NPV SWAP Short 1,859 4,439.0095 JPY
Ordinary NPV SWAP Short 2,084 4,440.0700 JPY
Ordinary NPV SWAP Short 3,133 4,429.4715 JPY
Ordinary NPV SWAP Short 6,961 4,452.5152 JPY
Ordinary NPV CFD Short 51,900 4,476.0000 JPY
Ordinary NPV SWAP Short 51,900 4,476.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 22 Nov 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

143221.01

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Call Options Written -10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Put Options Purchased -10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Put Options Written 10,000,000 4562.0355 European 4 Dec 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181122005247/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value8,756.54
Change-2.45